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Abstract
Ovine herpesvirus 2 (OvHV-2) is endemic in sheep populations worldwide and causes malignant
catarrhal fever (MCF), a lymphoproliferative disease, in cattle, bison and deer. OvHV-2 has been placed
in the gammaherpesvirus subfamily and is related closely to Alcelaphine herpesvirus 1 (AlHV-1). Here,
the cloning, sequencing and analysis of the complete OvHV-2 genome derived from a lymphoblastoid
cell line from an affected cow (BJ1035) are reported. The unique portion of the genome consists of 130
930 bp, with a mean G+C content of 52 mol%. The unique DNA is flanked by multiple copies of
terminal repeat elements 4205 bp in length, with a mean G+C content of 72 mol%. Analysis revealed 73
open reading frames (ORFs), the majority (62) of which showed homology to other gammaherpesvirus
genes. A further subset of nine ORFs is shared with only the related AlHV-1. Three ORFs are entirely
unique to OvHV-2, including a spliced homologue of cellular interleukin-10 that retains the exon
structure of the cellular gene. The sequence of OvHV-2 is a critical first step in the study of the
pathogenesis and treatment of MCF.
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Ovine herpesvirus 2 (OvHV-2) is endemic in sheep populations worldwide and causes malignant
catarrhal fever (MCF), a lymphoproliferative disease, in cattle, bison and deer. OvHV-2 has been
placed in the gammaherpesvirus subfamily and is related closely to Alcelaphine herpesvirus 1
(AlHV-1). Here, the cloning, sequencing and analysis of the complete OvHV-2 genome derived
from a lymphoblastoid cell line from an affected cow (BJ1035) are reported. The unique portion of
the genome consists of 130930 bp, with a mean G+C content of 52 mol%. The unique DNA is
flanked by multiple copies of terminal repeat elements 4205 bp in length, with a mean G+C
content of 72 mol%. Analysis revealed 73 open reading frames (ORFs), the majority (62) of which
showed homology to other gammaherpesvirus genes. A further subset of nine ORFs is shared with
only the related AlHV-1. Three ORFs are entirely unique to OvHV-2, including a spliced homologue
of cellular interleukin-10 that retains the exon structure of the cellular gene. The sequence of
OvHV-2 is a critical first step in the study of the pathogenesis and treatment of MCF.
INTRODUCTION
Malignant catarrhal fever (MCF) is a severe, usually fatal,
lymphoproliferative and inflammatory syndrome of domes-
tic cattle, pigs, deer and certain other susceptible ruminants,
such as bison. Cases of MCF in cattle usually occur
sporadically. However, periodically limited epizootic out-
breaks occur (Hamilton, 1990), where losses can be
substantial. The disease is mainly caused by either of two
closely related bovid gammaherpesviruses (cHVs),
Alcelaphine herpesvirus 1 (AlHV-1) and Ovine herpesvirus
2 (OvHV-2), that persist subclinically in their natural host.
These viruses are related closely in biological properties and
sequence to each other and to a recently identified virus,
porcine lymphotropic herpesvirus 1 (PLHV-1), that causes
post-transplant lymphoproliferative disease in pigs (Goltz
et al., 2002). OvHV-2 and AlHV-1 are related more distantly
to other cHVs, such as herpesvirus saimiri (HVS), Kaposi’s
sarcoma-associated herpesvirus (KSHV), Epstein–Barr
virus (EBV) and Murid herpesvirus 4 (MuHV-4). AlHV-1
naturally infects wildebeest (Connochaetes spp.) and is the
source of wildebeest-associated MCF in Africa (Plowright
et al., 1960). OvHV-2 is endemic in domestic sheep (Ovis
aries), which act as a reservoir of infection for the other main
form of the disease, sheep-associated MCF (SA-MCF)
(Baxter et al., 1993; Li et al., 1998; Mu¨ller-Doblies et al.,
1998;Wiyono et al., 1994). Aside from sporadic outbreaks in
domestic cattle, SA-MCF is themost important virus disease
of farmed deer and has recently been reported in pigs (Albini
et al., 2003; Loken et al., 1998). SA-MCF is also currently a
disease of great concern in Indonesia, affecting Bali cattle,
and in the USA, where bison are particularly susceptible (Li
et al., 2006; O’Toole et al., 2002; Schultheiss et al., 2000).
In the reservoir species, sheep, OvHV-2 DNA has been
found by PCR in B cells in the bloodstream, lymph nodes
and the respiratory, alimentary and urogenital tracts (Baxter
et al., 1997; Hu¨ssy et al., 2002). OvHV-2 DNA has also been
detected in nasal and ejaculatory secretions, suggesting
possible respiratory- and sexual-transmission mechanisms
(Hu¨ssy et al., 2002; Li et al., 2004). Moreover, cattle have
been infected experimentally with nasal secretions from
infected sheep, showing that respiratory transmission is
likely (Taus et al., 2006). In contrast, in SA-MCF-affected
ruminants, virus DNA is usually detected by PCR in lymph
nodes and spleens (Mu¨ller-Doblies et al., 2001) and has been
observed by in situ hybridization in hyperplastic T cells in
brain lesions (Simon et al., 2003). Thus, to enable the study
of the interaction of OvHV-2 with host cells, T-lympho-
blastoid cell lines with the morphology of large granular
lymphocytes (LGLs) have been established in culture from
The GenBank/EMBL/DDBJ accession number for the sequence
reported in this paper is AY839756.
28 0008-2284 G 2007 SGM Printed in Great Britain
Journal of General Virology (2007), 88, 28–39 DOI 10.1099/vir.0.82284-0
the tissues of MCF-affected animals (Reid et al., 1983, 1989;
Schock & Reid, 1996; Swa et al., 2001). These T-cell lines
contain OvHV-2 DNA and antigen (Baxter et al., 1993;
Bridgen & Reid, 1991; Swa et al., 2001) and can transmit
MCF experimentally to rabbits and hamsters (Buxton et al.,
1984, 1988), which are used as animal models. OvHV-2-
positive LGLs generally have a T-cell phenotype, are
constitutively and indiscriminately (non-major histocom-
patibility complex-restricted) cytotoxic and produce a range
of cytokines, but not interleukin-2 (IL-2) (Schock & Reid,
1996; Schock et al., 1998; Swa et al., 2001). Our current
hypothesis is that MCF is due to indiscriminate tissue
damage caused by dysregulated cytotoxic T cells generated
as a consequence of infection. The LGL T cells in culture
represent the virus-infected cells in vivo and are invaluable
for virus–cell interaction studies in MCF.
AlHV-1 has been isolated, will infect epithelial cell lines
productively in culture and has been sequenced completely
(Ensser et al., 1997; Plowright et al., 1960). In contrast,
research on OvHV-2 has lagged behind, due to the lack of a
productive tissue-culture system and reagents. This work
describes the complete sequence of the OvHV-2 genome as a
first step in the detailed molecular analysis of SA-MCF. An
accompanying manuscript by Taus et al. (2007) describes a
comparison of our sequence with that of OvHV-2 derived
from the nasal secretions of sheep.
METHODS
Cells and virus. The OvHV-2-infected bovine T-cell line BJ1035
was derived from a cow with SA-MCF (Schock et al., 1998). This
line was maintained in Iscove’s modified Dulbecco’s medium sup-
plemented with 2 mM glutamine (Invitrogen), 100 IU penicillin
ml21, 100 mg streptomycin ml21, 10% heat-inactivated fetal bovine
serum and 350 IU IL-2 ml21 (Proleukin; Chiron Therapeutics).
Construction of a cosmid library. A cosmid library containing
OvHV-2 DNA was generated from BJ1035 cells by using Supercos1
(Stratagene), modified as described by Cunningham & Davison
(1993) (a kind gift of Dr A. Davison, MRC Virology Unit,
University of Glasgow, Glasgow, UK). High-molecular-mass DNA
extracted from BJ1035 cells was digested partially with MboI such
that the products were on average 40 kb in size. A cosmid library
was then generated in Supercos1 from the MboI-digested BJ1035
DNA as described in the Supercos1 manual (Stratagene). Briefly,
cosmid arms generated from the vector by restriction-enzyme diges-
tion and dephosphorylation were ligated to MboI-cut BJ1035 DNA.
Ligated DNA was packaged into recombinant l phage by using a
Gigapack III XL packaging kit (Stratagene) according to the manu-
facturer’s instructions. The library was then amplified once using
Escherichia coli XL-1 Blue MR and stored at 280 uC.
Screening cosmid library. Bacterial colonies from the cosmid
library were screened by colony hybridization at high stringency
(Sambrook et al., 1989) using probes of known OvHV-2 sequence.
DNA probes of 300–500 bp in length were generated by PCR ampli-
fication using either DNA extracted from OvHV-2-infected cell lines
or cosmid DNA as a template. DNA probes were labelled with
[a-32P]dCTP by using a random-primed DNA labelling kit (Roche).
Positive colonies underwent a second round of screening. Cosmid
DNA was prepared from colonies positive on the second screen by
using QIAspin mini prep kits (Qiagen). The ends of the inserted
DNA were then sequenced by using the vector-specific primers 59-
AAGGAAACGACAGGTGCTG and 59-CGAAAATGTCCACCTGAC-
GTC, which lie either side of the insert sites in the modified
Supercos1.
DNA sequencing. DNA sequencing was performed by using the
dideoxy chain-termination sequencing method. Sequencing of
cosmid ends, splinkerette products and plasmids containing the
terminal repeat elements was performed by using either the in-house
sequencing service at the Department of Veterinary Pathology,
University of Edinburgh, UK, or via Lark Technologies.
Sequencing of the four overlapping cosmid clones was performed by a
shotgun library approach using pCR4bluntTopo (Invitrogen). Plasmid
subclones were cycle-sequenced with BigDye Terminator version 1.0
reagents (Applied Biosystems) and analysed on a MegaBACE 1000
sequencer (Amersham Biosciences) or an ABI 377 sequencer (Applied
Biosystems). Computer-assisted assembly was done with Lasergene
SeqMan (DNASTAR Inc.) with five- to sevenfold redundancy.
PCR amplification. PCRs of 50 ml total volume contained 16
PCR buffer [20 mM Tris (pH 8.4), 50 mM KCl; Invitrogen], 1.5 mM
MgCl2, 250 mM each of dATP, dGTP, dCTP and dTTP (Ultrapure
dNTP set; Amersham Biosciences), 200 pmol each primer,
100–500 ng DNA template and 1 U Taq DNA polymerase
(Invitrogen). PCR primers were obtained from MWG-Biotech. PCR
programs generally consisted of 30–40 cycles of 30 s denaturing at
94 uC, 1 min annealing at 55–60 uC and extension at 72 uC for 1 min
(kb product)21. To generate PCR products across the genome ter-
mini, a GC-rich PCR kit (Roche Diagnostics) was used in combina-
tion with primers homologous to the ends of the known sequence.
The genome co-ordinates of the primers were as follows: sense,
128577–128598; antisense, 467–487.
Analysis of OvHV-2 gene splicing by RT-PCR. Total RNA was
isolated from BJ0135 cells by extraction using RNeasy kits (Qiagen)
according to the manufacturer’s guidelines, digested with RQ1
DNase (Promega) (0.1 U ml21) for 30 min at 37 uC, extracted
sequentially in phenol/chloroform and chloroform and then precipi-
tated in ethanol. cDNA was synthesized from 2 mg total RNA with
SuperScript II reverse transcriptase (Invitrogen) primed with an
oligo(dT) adapter primer (Gibco-BRL) in a 20 ml reaction according
to the manufacturer’s recommendations. Aliquots (1 ml) of cDNA
were then amplified by PCR using primers specific for OvHV-2
ORFs. Amplified cDNAs were then analysed by gel electrophoresis,
inserted into the cloning vector pCR2.1-TOPO and multiple clones
for each cDNA were sequenced. The genome co-ordinates for pri-
mers used for RT-PCR are as follows: Ov2, sense 2813–2792, anti-
sense 2162–2183; Ov2.5, sense 3576–3597, antisense 4455–4434;
Ov6, sense 79355–79375, antisense 80327–80307; ORF57, sense
89060–89072, antisense 90482–90460; Ov8, sense 81538–81560, anti-
sense 83906–83886; Ov8.5, sense 117777–117796, antisense
118950–118930.
Genome walking by splinkerette PCR. Splinkerette PCR is a
method of extending from known to unknown sequence by amplifi-
cation of DNA sequences that lie between a single known primer
and a nearby restriction site (Devon et al., 1995). Splinkerette PCR
was performed on BJ1035 DNA exactly as described by Devon et al.
(1995). Oligonucleotide adapters specific for the enzymes BamHI,
HindIII, SalI and EagI were utilized. PCR products generated were
cloned by using a pCR2.1-TOPO TA cloning kit (Invitrogen)
according to the manufacturer’s instructions. Multiple clones (five
to seven) from each walk were sequenced.
Nucleotide and protein sequence analysis. The EMBOSS (Rice
et al., 2000) package of programs was used for final assembly and
analysis of sequences, including gene finding. The definition of open
reading frames (ORFs) was performed by using the GeneMarkS
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program with the eukaryotic virus option (Besemer et al., 2001), as
well as by comparison with other herpesviruses and mammalian
genes using the NCBI BLAST programs (Altschul et al., 1990; Gish &
States, 1993). Annotation was performed by using the Artemis pro-
gram (Rutherford et al., 2000).
RESULTS AND DISCUSSION
Molecular cloning and sequencing of the OvHV-2
genome
There is currently no productive culture system for OvHV-2.
DNA for sequencing of the OvHV-2 genome was therefore
obtained from the OvHV-2-positive bovine T-cell line
BJ1035. This cell line was derived from an MCF-affected
cow. We were unable to clone the BJ0135 line prior to
sequencing. Indeed, it has never been possible to clone T-cell
lines carrying OvHV-2 (H. Reid, unpublished observations).
However, previous studies have shown that BJ1035 contains
a mean of between 40 and 400 copies of episomal OvHV-2
genome per cell (J. Hart & J. P. Stewart, unpublished
observations).
The cloning and sequencing strategy is shown in Fig. 1 and
the co-ordinates of relevant clones are detailed in Table 1. A
cosmid library was made by using total high-molecular-
mass DNA from BJ1035 cells. An initial OvHV-2 cosmid
(c75) was isolated by using a probe consisting of part of
ORF75 (Bridgen & Reid, 1991). Cosmid clones correspond-
ing to a large part of the unique portion of the genome were
then isolated successively by using probes derived from the
ends of the cosmid inserts. The DNA sequence of these
cosmids was determined after shotgun cloning into
pCR4bluntTopo and sequencing. Despite repeated
attempts, we were unable to isolate further cosmid clones
that spanned or contained genome termini. To complete the
genome sequence, successive splinkerette PCRs were
performed, walking away from the known sequence.
However, upon reaching high G+C content and repetitive
sequence, corresponding to terminal repeat elements (TRs),
we were unable to proceed any further with this technique.
As most of the OvHV-2 genomes in BJ1035 are circular
(Rosbottom et al., 2002; Thonur et al., 2006), PCR
amplification using primers homologous to the ends of
the known sequence and a GC-rich PCR kit (Roche
Diagnostics) was used to generate independent plasmid
clones that completed a circular sequence. Analysis of
several independent clones (represented by p3.5) revealed
that they were identical in sequence and that there was a
Fig. 1. Molecular cloning of the OvHV-2 genome. High-molecular-
mass DNA was extracted from the OvHV-2-infected cow LGL line
BJ1035 and initially used to construct a cosmid library. The positions
of individual clones are shown as horizontal arrows above the repre-
sentation of the viral genome as a solid line (unique DNA) or open
squares (terminal repeats). Nucleotide base numbers are shown
below in kbp. The first cosmid clone (c75) was isolated by using a
probe to a known sequence (Q). Subsequent cosmids were isolated
by using probes derived from the cosmid ends. Sequences to the
end of the unique portion of the genome and the terminal repeats
were derived by a series of splinkerette walks and, finally, cloning of
the terminal repeats into a plasmid as described in the text.
Table 1. Genome co-ordinates of clones used in sequence determination
Clone name Description Enzyme used to
generate clone
Genome co-ordinates (nt)
From To
c8 Cosmid from library MboI 2628 44562
c33 Cosmid from library MboI 25375 68382
c57 Cosmid from library MboI 58319 98615
c75 Cosmid from library MboI 89612 128522
pSPL1 Plasmid generated from splinkerette HindIII 1623 2679
pSPL2 Plasmid generated from splinkerette BamHI 824 1668
pSPL3 Plasmid generated from splinkerette SalI 410 887
pSPL4 Plasmid generated from splinkerette EagI 135 495
pSPLR1 Plasmid generated from splinkerette BamHI 128486 128666
p3.5 Plasmid generated from PCR across genome termini 128577 131582
1 487
pH4.2 Plasmid generated from genomic DNA HindIII 130931 131172
131167 135135
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GC-rich region of approximately 600 bp within each clone.
As the TRs of cHVs are GC-rich, we surmised that this could
correspond to one copy or part of the TR element. However,
it was impossible to determine the boundaries of the unique
region and TR by using this clone. Analysis revealed a
unique HindIII site in the centre of the 600 bp GC-rich
region in p3.5. To determine the exact nature of the TR unit,
BJ1035 DNA was therefore cut withHindIII and analysed by
Southern blotting using p3.5 as a probe (not shown). This
revealed a hypermolar fragment of approximately 4.2 kbp in
length, corresponding to one TR unit. The 4.2 kbp HindIII
fragment was subsequently cloned into the vector
pBluescript KS+ (Stratagene). A number of clones with
the same sequence, containing one unit of the TR (pH4.2),
were isolated. Comparison of the sequences of p3.5 and
pH4.2 allowed the definition of the boundaries of the unique
and TR DNA and additionally showed that the PCR
fragment in p3.5 was generated from a circular, defective
OvHV-2 genome containing only a single, deleted TR unit.
The boundaries of the TR and unique DNA were further
confirmed by PCR analysis and sequencing.
In line with the convention for other cHVs, the OvHV-2
sequence was assembled in the same orientation as that of
HVS (Albrecht et al., 1992), with the sequence of one copy of
the TR placed after the end of the unique sequence. The
sequence of the unique region was 130 930 bp in length,
with a mean G+C content of 52 mol%, and the sequence of
Fig. 2. Organization of the OvHV-2 BJ1035
genome. ORFs are shown by open arrows,
with the arrow showing the direction of tran-
scription/translation, and non-coding DNA as
a solid line. The ORFs are drawn to scale
with the relative co-ordinates shown below
in kbp. Splice sites are shown as lines
above connecting exons. Potential polyadeny-
lation signals (AATAAA or ATTAAA) are
shown for the respective forward (Q) or
reverse (q) DNA strands. Major repetitive
elements are shown as shaded rectangles,
direct repeats as hashed blocks and inverted
repeats as solid bars.
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one TR unit was 4205 bp in length, with a mean G+C
content of 72 mol%.
Repeat regions in the unique portion of the
OvHV-2 genome
In addition to the TRs, analysis of the unique portion of the
genome using the EMBOSS programs EQUICKTANDEM and
EINVERTED revealed six tandem- and two inverted-repeat
structures. These are shown in Fig. 2 and detailed in the
GenBank entry (accession no. AY839756). Five of the
tandem-repeat elements are contained within coding
regions, two within the unique ORF Ov8.5 and three
within ORF73. Repeats within ORF73 homologues are also
seen in related viruses, such as AlHV-1 and KSHV. Repeats at
the same position as those within Ov8.5 are seen in a number
of cHVs [e.g. Bovine herpesvirus 4 (BoHV-4), MuHV-4 and
KSHV] and are known to form part of the lytic origins of
replication in these viruses (AuCoin et al., 2002; Deng et al.,
2004; Lin et al., 2003; Zimmermann et al., 2001). Thus, this
region of the genomemay also act as a lytic origin inOvHV-2.
The two inverted repeats are located in a long region of
apparently non-coding DNA between ORFs 11 and 17.5.
Although not conserved in sequence, these repeats are
positionally analogous to two inverted repeats in the AlHV-
1 genome (Ensser et al., 1997). They may therefore perform
a conserved function, such as origin of DNA replication.
Coding potential of the OvHV-2 genome
Computer-assisted analysis predicted 73 ORFs in the
OvHV-2 genome (Fig. 2; Table 2). Potential protein-
encoding ORFs were identified by the following criteria:
ORF size larger than 60 aa, presence of potential transcrip-
tional start and stop sites, a high GeneMark score and
homology to other known herpesvirus or cellular ORFs. In
line with the nomenclature of other cHVs, where applicable,
ORFs were assigned the number of the homologue in HVS.
When possible, ORFs with homologues shared only with
AlHV-1 were assigned the same number as in AlHV-1, but
with the Ov prefix for ovine. ORFs with no homologues in
HVS or AlHV-1 were assigned an Ov prefix with numbers
between the adjacent Ov ORFs.
The arrangement of ORFs within the genome was highly
similar to those of other cHVs. The genome structure, ORF
content and similarity of amino acid sequence were closest
to those of AlHV-1, with many AlHV-1 ‘unique’ ORFs also
being found in OvHV-2. A comparison of the AlHV-1 and
OvHV-2 genomes is shown in Fig. 3. Conserved OvHV-2
ORFs were arranged in four blocks collinear with other
cHVs, as indicated in Table 2 and Fig. 3.
Non-conserved and unique ORFs
Outside the four conserved blocks are ORFs that are unique
to OvHV-2 or only conserved in the closely related viruses
AlHV-1 (Albrecht et al., 1992) and PLHV-1 (Goltz et al.,
2002). The validity of all candidate OvHV-2-unique ORFs
(those with an Ov prefix) has been confirmed, as mRNAs
corresponding to all of these ORFs were detected in OvHV-
2-infected cells (Thonur et al., 2006).
The left end of the unique region contains four ORFs. ORFs
Ov2 and Ov3 are homologous to AlHV-1 A2 and A3,
respectively. Ov2 contains two exons, as confirmed by RT-
PCR and sequencing. It encodes a protein containing a basic
leucine-zipper (bZIP) motif, is homologous to ATF-like,
CREB and Jun dimerization proteins and is therefore likely
to be a transcription factor. The product of Ov3 contains a
putative signal peptide to residue 22 and, like AlHV-1 A3, is
homologous to proteins of the semaphorin family.
However, Ov3 is shorter than A3 by 200 aa at the C-
terminus, the truncation occurring just after the consensus
Sema domain (InterPro IPR001627). There is a short stretch
of collinear homology between A3 and the region down-
stream of the stop codon for the Ov3 ORF. In addition, the
Ov3 ORF has a long predicted 39 untranslated region,
making the gene a similar length [predicted TATA to
poly(A) signal] to the A3 gene. It seems likely, therefore, that
the Ov3 ORF is the product of truncation of a longer ORF.
The Ov3 protein shows the greatest similarity in amino acid
sequence to semaphorin 7A (CDw108) and poxvirus
semaphorins, e.g. vaccinia virus A39R. Semaphorin 7A is
expressed by lymphoid and myeloid cells and, like A39R, is a
potent monocyte activator (Comeau et al., 1998; Holmes
et al., 2002). Thus, Ov3 may be involved in the modulation
of the host response to OvHV-2.
There are no homologues of the AlHV-1 A1 and A4 ORFs in
OvHV-2. Instead, there are two unique ORFs, Ov2.5 and
Ov3.5. Ov2.5 contains five exons (as confirmed by RT-PCR
and sequencing) and encodes a homologue of cellular IL-10.
This ORF is interesting, in that it retains precisely the exon
structure of the cellular gene, unlike other herpesvirus IL-10
homologues. Ov2.5 has also been shown to encode a
functional IL-10 molecule that can block cytokine secretion
by macrophages and stimulate proliferation of mast cells (J.
P. Stewart & D. M. Haig, unpublished observations) and
may thus be involved in the modulation of the host response
to OvHV-2. In contrast, Ov3.5 has no significant homology
to any known protein, encodes a peptide of 163 aa and
contains a putative signal peptide. It is therefore likely to be
secreted from the infected cell.
Between conserved ORFs 03 and 06 lies the Ov4.5 ORF. This
encodes a protein with homology to the EBV BALF1, equine
herpesvirus 2 E6 and cellular Bcl-2 proteins. Comparative
sequence analysis of the AlHV-1 genome showed that a
homologous ORF, now termed A4.5, was not reported in the
published description of the sequence (Ensser et al., 1997). A
secondOvHV-2ORF, Ov9, also encodes a Bcl-2 homologue.
This ORF is situated at the right-hand end of the unique
region and is homologous to AlHV-1 A9. Thus, like EBV, it
appears that OvHV-2 (and AlHV-1) encodes two Bcl-2
family homologues. In EBV, BHRF1 is anti-apoptotic,
whereas the role of BALF1 is controversial, being reported as
both pro- and anti-apoptotic in transfected cell lines
(Bellows et al., 2002; Marshall et al., 1999). Recent deletion
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Table 2. Open reading frames encoded by by OvHV-2 and their putative functions
Gene
block*
OvHV-2 ORF Strand ExpressionD Start
codond
Stop
codond
TATA§ Poly(A)§ Length
(aa)
AlHV-1
id (%)||
HVS id
(%)||
Description
Ov2 Exon 2 2 + SA:2569 2159 1326 186 56 NA Basic leucine-zipper motif; homologue of AlHV-1 A2
Exon 1 2 2813 SD:2664 2840
Ov2.5 Exon 1 + 3576 SD:3761 3520
Exon 2 + SA:3844 SD:3903
Exon 3 + SA:3985 SD:4137
Exon 4 + SA:4229 SD:4294
Exon 5 + + SA:4375 4458 4503 182 NA NA vIL-10
Ov3 + + 4801 6177 4641 6755 458 50 NA Semaphorin; homologue of AlHV-1 A3
Ov3.5 + + 6911 7402 6843 7432 163 NA NA Signal peptide
ORF03 + 7654 11739 7609 11759 1361 52 28 FGARAT; tegument protein
Ov4.5 + + 11795 12433 11758 12429 212 50 NA vBcl-2; homologue of EBV BALF1
I
ORF06 + 12575 15964 12501 16156 1129 79 50 Single-stranded DNA-binding protein
ORF07 + 16039 18087 15627 682 65 41 Subunit of terminase
ORF08 + 18071 20662 17905 20763 863 76 44 Glycoprotein B
ORF09 + 20857 23853 20718 24031 998 75 56 DNA polymerase, catalytic subunit
Ov5 + + 24135 25388 23830 417 49 NA GPCR; homologue of AlHV-1 A5 and EBV BILF1
ORF10 + 25108 26328 24887 406 56 21 Non-essential for replication
ORF11 + 26330 27562 26103 27600 410 56 30 Virion component; non-essential for replication
II
ORF17 2 38557 36899 38646 36852 552 50 34 Maturational protease; capsid protein
ORF17.5 2 37726 36899 37873 36852 275 42 29 Major scaffold protein
ORF18 + 38514 39344 38350 276 68 45
ORF19 2 40997 39318 41111 39299 559 74 41 Tegument protein; putative portal-capping protein
ORF20 2 41538 40786 41641 250 61 41 Nuclear protein
ORF21 + 41537 43246 41233 569 47 29 Thymidine kinase
ORF22 + 43267 45519 43165 45522 750 63 27 Glycoprotein H
ORF23 2 46714 45512 46920 45463 400 58 34 Tegument protein
ORF24 2 48909 46720 49012 46702 729 70 41
ORF25 + 48908 53011 48789 1367 81 57 Major capsid protein forming pentons and hexons
ORF26 + 53077 53991 52980 304 83 48 Capsid triplex protein
ORF27 + 53997 54878 53945 54955 293 51 28 Glycoprotein; involved in cell–cell spread
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ORF29 Exon 2 2 SA:56110 54965 54969 687 82 58 ATPase subunit of terminase
ORF30 + 56128 56379 56021 56738 83 57 33
ORF31 + 56301 56975 224 67 41 Essential for replication
ORF32 + 56924 58354 56868 476 48 25 Nuclear capsid localization
ORF33 + 58344 59363 58288 59679 339 52 37 Tegument protein
ORF29 Exon 1 2 60270 SD:59353 60410
ORF34 + 60269 61282 337 63 37
ORF35 + 61260 61721 60970 153 59 29 Tegument protein
ORF36 + 61615 62937 64175 440 55 33 Protein kinase
ORF37 + 62921 64378 62729 485 79 42 Alkaline exonuclease
ORF38 + 64333 64518 64224 64525 61 49 47 Myristylated tegument protein; role in egress
ORF39 2 65790 64564 65868 64568 408 80 44 Glycoprotein M
ORF40 Exon 1 + 65834 SD:67180 65773
ORF40 Exon 2 + SA:67304 67861 67956 634 48 26 Complexed with helicase–primase
ORF42 2 68631 67858 68713 67845 257 64 3 Tegument protein
ORF43 2 70291 68603 70642 562 83 54 Capsid portal protein
ORF44 + 70146 72638 70084 72637 830 78 55 Helicase
ORF45 2 73479 72694 72684 261 37 22 Nuclear phosphoprotein; essential for replication
ORF46 2 74267 73512 74361 251 71 56 Uracil DNA glycosylase
ORF47 2 74706 74251 74752 73839 151 45 28 Glycoprotein L
ORF48 2 76101 74761 76148 446 41 25
ORF50 Exon 1 + 76272 SD:76328 75986
ORF49 2 77341 76367 77394 76365 324 NA 23 Transcriptional control; EBV BRRF1 homologue
ORF50 Exon 2 + + SA:77379 79043 79196 573 36 22 Transcriptional control; Rta
Ov6 Exon 1 + 79355 SD:79879 79287
Ov6 Exon 2 + SA:79989 SD:80093
Ov6 Exon 3 + + SA:80189 80329 80384 256 28 NA Leucine-zipper motif; homologue of AlHV-1 A6
Ov7 + + 80901 81266 80846 81338 121 60 NA Putative glycoprotein; homologue of AlHV-1 A7
Ov8 Exon 1 + 81538 SD:82756
Ov8 Exon 2 + + SA:83704 83906 83906 473 41 NA Putative glycoprotein; homologue of AlHV-1 A8
ORF52 2 84375 83965 84433 83953 136 45 26
Table 2. cont.
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ORF53 2 84765 84457 84821 84461 102 51 35 Glycoprotein N
ORF54 + 84834 85715 84766 85750 293 57 36 dUTPase
ORF55 2 86415 85759 86479 85723 218 74 43
ORF56 + 86414 88927 89052 837 67 43 Primase
ORF57 Exon 1 + 89060 SD:89111 88953 433 51 23
ORF57 Exon 2 + SA:89214 90463 90485 Post-transcriptional regulator; Mta
ORF58 2 + 91970 90915 90929 351 60 26 Membrane-spanning; complexed with ORF27
ORF59 2 + 93146 91977 93241 389 63 33 Processivity factor of DNA polymerase
ORF60 2 94195 93278 94304 93660 305 80 57 Ribonucleotide reductase (small subunit)
ORF61 2 96604 94247 96794 94202 785 71 51 Ribonucleotide reductase (large subunit)
ORF62 2 97642 96635 97797 335 63 32 Capsid triplex protein
ORF63 + 97641 100484 97494 100947 947 61 27 Tegument protein
ORF64 + 100489 108363 100391 108392 2624 50 24 Large tegument protein
ORF65 2 109063 108428 109170 108234 211 41 Capsid protein on hexon tips
ORF66 2 110427 109120 110574 109121 435 60 36
ORF67 2 111122 110346 111277 258 68 51 Capsid docking protein on nuclear lamina
ORF67a 2 111384 111130 111482 84 69 48 Interacts with terminase
ORF68 + 111604 113022 111534 113134 472 61 39 Nuclear capsid localization
ORF69 + 113029 113883 112941 113844 284 74 44 Capsid docking protein on nuclear lamina
Ov8.5 + + 117777 118949 117677 118969 390 NA NA Proline-rich
ORF73 2 + 120533 119046 120686 118971 495 43 LANA homologue; episomal maintenance
ORF75 2 125054 121104 125099 121023 1316 58 29 FGARAT; virion tegument protein
Ov9 + + 125436 126056 125375 126207 206 50 vBcl-2
Ov10 2 + 129326 127920 129392 127708 468 22 Putative nuclear protein; homologue of AlHV-1 A10
*Blocks of conserved core herpesvirus genes are separated by lines and indicated by Roman numerals.
DIndication of expression of mRNA specific for this ORF in OvHV-2-infected cells either in this study or others (Coulter & Reid, 2002; Thonur et al., 2006).
dThe position of the respective ORF on the genome is given from the first nucleotide of the first methionine codon or splice acceptor (SA) to the last nucleotide of the stop codon or splice donor
(SD).
§The first nucleotides of putative TATA boxes and polyadenylation signals (AATAAA or ATTAAA) are given.
||Percentage identity of herpesvirus ORFs to the respective OvHV-2 ORF (calculated with the BLAST algorithm with default parameters).
Possible functions for the OvHV-2 proteins are deduced from the homologous ORFs described in other herpesviruses.
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analysis has, however, assigned an essential role for both
proteins in EBV transformation of B cells by protecting
newly infected cells from apoptosis prior to the establish-
ment of latency. Thus, it is possible that, in OvHV-2-
infected cells, the Ov4.5 and Ov9 products promote survival
of infected lymphocytes and the establishment of latency.
The Ov5 ORF is located downstream of ORF9/DNA
polymerase and overlaps with ORF10. This ORF is predicted
to encode a G protein-coupled receptor (GPCR) that is
homologous to the AlHV-1 A5, except that it is predicted to
have a longer C-terminal (intracellular) tail than A5.
Iteration of the PSI-BLAST program revealed that Ov5 is
also related to EBV BILF1 and more weakly to cellular IL-8
receptors. BILF1 functions as a constitutively signalling
(ligand-independent) GPCR that alters intracellular
signalling (Beisser et al., 2005; Paulsen et al., 2005); hence,
the Ov5 protein may fulfil a similar role in OvHV-2-infected
cells.
OvHV-2, like AlHV-1 and PLHV-1, is unusual amongst
cHVs in that it has no ORF28 homologue. ORF28 encodes a
non-essential virion glycoprotein in other cHVs (Bortz et al.,
2003;May et al., 2005). Thus, the function of ORF28 is either
redundant or performed by a separate glycoprotein in this
subgroup of cHVs. However, unlike AlHV-1, OvHV-2 does
encode an ORF49 homologue. The ORF49 homologue of
EBV (BRRF1) has been shown to act as a transcriptional
transactivator that co-operates with the viral BRLF1
transactivator (ORF50) to induce lytic replication (Hong
et al., 2004). PLHV-1 also contains anORF49 homologue, so
AlHV-1 is highly unusual in not encoding a homologous
ORF and its absence is not a consistent feature of this group
of cHVs.
In between ORF50 and ORF52 lie three ORFs, Ov6, Ov7 and
Ov8. These all have homologues in AlHV-1 (A6, A7 and A8)
and in PLHV-1. Like the PLHV-1 homologue, Ov6 was
shown to consist of three exons, as determined by RT-PCR
analysis and sequencing. The product of Ov6 contains a
leucine-zipper motif in its C-terminal region and there are
consensus DNA-binding motifs towards the N terminus. It
also has significant sequence similarity to the CCAAT/
enhancer-binding protein family, consistent with it having a
putative role in transcriptional transactivation. In addition,
although there is no direct sequence relationship, Ov6 is
positionally analogous to EBV BZLF1 and KSHV K8, which
are both transactivators of the viral lytic cycle. It seems likely,
therefore, that Ov6 may fulfil a similar function during
OvHV-2 infection. The product of Ov7 contains a predicted
signal peptide and N-linked glycosylation motifs and is thus
likely to be a viral glycoprotein. Although there is no
sequence similarity, Ov7 is positionally analogous to EBV
BZLF2, whose product is involved in entry of EBV into B
cells via binding to HLA-DR (Spriggs et al., 1996). The Ov7
protein may also therefore be involved in receptor binding.
Ov8 was shown to consist of two exons by RT-PCR and
sequencing. These splice sites are conserved in the
homologous ORFs in AlHV-1 and PLHV-1 and correspond
to the regions of homology between these proteins. Thus,
the AlHV-1 A8 and PLHV-1 A8 may be spliced in a similar
fashion. The product of Ov8 was predicted to contain a
transmembrane anchor near the C terminus and N-linked
glycosylation sites and so, like Ov7, is likely to be a virus
glycoprotein. Also, like Ov7, although there is no sequence
similarity, Ov8 is positionally analogous to EBV BLLF1
(gp350/220), KSHV K8.1 and MuHV-4 ORF51, all of which
encode glycoproteins involved in binding to cellular
Fig. 3. Comparison of the genome organizations of OvHV-2 and AlHV-1. The organization of OvHV-2 is shown relative to
that of AlHV-1 below. ORFs are shown as block arrows with shading representing the conservation of genes as follows: light
shading, ORFs common to cHVs; no shading, ORFs only found in OvHV-2 and AlHV-1; solid shading, ORFs unique to OvHV-
2 or AlHV-1.
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receptors (Birkmann et al., 2001; Stewart et al., 2004; Tanner
et al., 1987). Thus, the Ov8 protein may also be involved in
binding to cellular receptors.
Downstream of ORF73 lies Ov8.5, which is unique to
OvHV-2 and shows no obvious similarity to any viral or
cellular gene. Ov8.5 is predicted to encode a proline-rich
(24%) peptide of molecular mass 42 kDa that contains no
consensus motifs, as defined by the PROSITE database.
However, RNA from Ov8.5 is found in OvHV-2-infected
cells (Thonur et al., 2006) and, so, this is a bone fide ORF.
The N-terminal region of the Ov8.5 protein is encoded by
two DNA direct-repeat elements. Direct-repeat elements
that form part of the origins of virus DNA replication are
present in the analogous genomic location in other cHVs,
e.g. BoHV-4, KSHV and MuHV-4 (AuCoin et al., 2002;
Deng et al., 2004; Lin et al., 2003; Zimmermann et al., 2001).
In BoHV-4 and KSHV, unique ORFs (Bo11, Bo12 and K12)
are also found surrounding the repeat. Thus, the presence of
a direct repeat and unique ORF at a genomic location
analogous to that of Ov8.5 appears to be a common feature
of cHVs. Further studies are required to show whether this
region acts as an origin of DNA replication and to assign a
function to Ov8.5.
Directly upstream of Ov8.5 is ORF73. This shows significant
similarity to ORF73 of other cHVs, including KSHV.
However, the similarity is largely restricted to the C-
terminal region. Like other homologues, OvHV-2 ORF73
incorporates a large acidic-repeat domain. Variability in the
length of the acidic-repeat domain is seen between isolates of
KSHV and HVS ORF73 proteins (Ensser et al., 2003; Gao
et al., 1999; Zhang et al., 2000). In an accompanying study,
Taus et al. (2007) show that ORF73 derived from the nasal
secretions of sheep varied from the sequence reported here
in the length of the acidic domain. It is not clear what
functional difference this variability makes. However,
differences in ORF73 sequence may be useful for epide-
miological studies. The KSHV ORF73 was described as a
latency-associated nuclear protein (LANA) that functions to
transactivate the viral latent origin of replication (Hu et al.,
2002). It seems likely, therefore, that the OvHV-2 homo-
logue will have a similar function.
The final unique ORF found was Ov10. This lies at the right-
hand end of the unique region between Ov9 and the
terminal repeats. This ORF shows limited similarity to
AlHV-1 A10. The predicted Ov10 protein has a potential
transmembrane anchor at the C terminus and four
consensus nuclear-localization signals. Thus, the Ov10
protein may localize to the nucleus of infected cells.
Conserved spliced ORFs
The region encoding ORF40/41 in OvHV-2 consisted of one
continuous ORF with regions that were homologous to
ORFs 40 and 41 of other herpesviruses. These ORFs are
conserved amongst all herpesviruses and encode a protein
that is complexed with helicase and primase. In many cHVs,
such as EBV (Fixman et al., 1995) and KSHV (AuCoin &
Pari, 2002; Wu et al., 2001), the coding sequence for
this protein is formed by splicing of two separate ORFs,
40 and 41. In other cHVs, such as MuHV-4, there is a
continuous ORF, but this is still spliced at conserved
splice sites (J. P. Stewart, unpublished observations). The
sequence of ORF40/41 of OvHV-2 contained conserved
splice sites that corresponded to regions of homology
to other cHV ORFs 40 and 41. It seems likely, therefore,
that OvHV-2 ORF40/41 is spliced in a fashion similar to
that of MuHV-4. Interestingly, the OvHV-2 sequence
derived from the nasal secretions of sheep, described by
Taus et al. (2007) in a complementary study, contains
an additional 2 nt in the predicted intron in ORF40/41,
resulting in two separate ORFs. To confirm the sequence
of the BJ1035 virus, PCR products across the region
were generated from BJ1035 cellular DNA, sequenced
and found to be identical to the original sequence. Thus,
within the OvHV-2 species, there are variants with either a
single or separate ORFs 40/41. However, this difference is
likely to be silent, as the predicted final transcripts are
identical.
The transcripts for viral terminase (ORF29), transcriptional
transactivator (Rta/ORF50) and ORF57 are known to be
formed from the splicing of two exons in other cHVs.
Consensus potential splice-donor and -acceptor sites for
these OvHV-2 homologues (Table 2) were present and
determined by comparative sequence analysis.
Similarity to other MCF-associated viruses
It has been proposed that the cHVs associated with MCF be
placed in their own genus, Macavirus (McGeoch et al.,
2006), based on evolutionary relatedness of conserved ORF
sequences. The sequence presented here confirms this new
grouping, showing that OvHV-2 is highly similar to AlHV-1
and PLHV-1, not only in the nucleotide similarity of
conserved ORFs, but also in terms of ORFs that are present
only in this group of viruses. These macavirus-specific ORFs
are likely to be involved in host-specific pathogenesis and
the development of MCF. Thus, comparative genetic
analysis of OvHV-2 and related viruses enabled by the
completion of this sequence will be core to the under-
standing of the mechanisms underlying MCF.
The sequence of OvHV-2 derived from the nasal secretions
of sheep, published in a complementary study by Taus et al.
(2007), shows that, whilst the two genomes are extremely
similar, there are differences. As the outbreaks of MCF in
European cattle are sporadic in nature, it has been
hypothesized that they could be due to the generation of
more pathogenic OvHV-2 variants. Analysis of the sequence
differences between the nasal-secretion virus (derived from
the reservoir species) and the sequence derived from a
clinically affected cow (BJ1035) will be important to
determine whether these are relevant to pathogenicity in
cattle.
http://vir.sgmjournals.org 37
Ovine herpesvirus 2 genome
ACKNOWLEDGEMENTS
This work was supported by a Biotechnology and Biological
Sciences Research Council (BBSRC)/Scottish Executive Environment
and Regional Affairs Department joint project grant reference 26/
S16844 to J. P. S. and D.M.H., and grant 3100A0-12498 from the
Swiss National Science foundation to M. A. J. H. was supported by a
BBSRC CASE award studentship in partnership with Moredun
Research International Ltd grant reference 99/V2/S/05157. J. P. S. is a
Royal Society University Research Fellow. The authors wish to
thank Dr Andrew Davison for the modified Supercos1 vector and
helpful advice relating to cosmid cloning and herpesvirus genome
annotation.
REFERENCES
Albini, S., Zimmermann, W., Neff, F., Ehlers, B., Ha¨ni, H., Li, H.,
Hu¨ssy, D., Engels, M. & Ackermann, M. (2003). Identification and
quantification of ovine gammaherpesvirus 2 DNA in fresh and
stored tissues of pigs with symptoms of porcine malignant catarrhal
fever. J Clin Microbiol 41, 900–904.
Albrecht, J.-C., Nicholas, J., Biller, D., Cameron, K. R., Biesinger, B.,
Newman, C., Wittmann, S., Craxton, M. A., Coleman, H. & other
authors (1992). Primary structure of the herpesvirus saimiri
genome. J Virol 66, 5047–5058.
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J.
(1990). Basic local alignment search tool. J Mol Biol 215, 403–410.
AuCoin, D. P. & Pari, G. S. (2002). The human herpesvirus-8
(Kaposi’s sarcoma-associated herpesvirus) ORF 40/41 region encodes
two distinct transcripts. J Gen Virol 83, 189–193.
AuCoin, D. P., Colletti, K. S., Xu, Y., Cei, S. A. & Pari, G. S. (2002).
Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8)
contains two functional lytic origins of DNA replication. J Virol 76,
7890–7896.
Baxter, S. I. F., Pow, I., Bridgen, A. & Reid, H. W. (1993). PCR
detection of the sheep-associated agent of malignant catarrhal fever.
Arch Virol 132, 145–159.
Baxter, S. I. F., Wiyono, A., Pow, I. & Reid, H. W. (1997).
Identification of ovine herpesvirus-2 infection in sheep. Arch Virol
142, 823–831.
Beisser, P. S., Verzijl, D., Gruijthuijsen, Y. K., Beuken, E., Smit, M. J.,
Leurs, R., Bruggeman, C. A. & Vink, C. (2005). The Epstein-Barr virus
BILF1 gene encodes a G protein-coupled receptor that inhibits
phosphorylation of RNA-dependent protein kinase. J Virol 79, 441–449.
Bellows, D. S., Howell, M., Pearson, C., Hazlewood, S. A. &
Hardwick, J. M. (2002). Epstein-Barr virus BALF1 is a BCL-2-like
antagonist of the herpesvirus antiapoptotic BCL-2 proteins. J Virol
76, 2469–2479.
Besemer, J., Lomsadze, A. & Borodovsky, M. (2001). GeneMarkS: a
self-training method for prediction of gene starts in microbial
genomes. Implications for finding sequence motifs in regulatory
regions. Nucleic Acids Res 29, 2607–2618.
Birkmann, A., Mahr, K., Ensser, A., Yag˘ubog˘lu, S., Titgemeyer, F.,
Fleckenstein, B. & Neipel, F. (2001). Cell surface heparan sulfate is a
receptor for human herpesvirus 8 and interacts with envelope
glycoprotein K8.1. J Virol 75, 11583–11593.
Bortz, E., Whitelegge, J. P., Jia, Q., Zhou, Z. H., Stewart, J. P., Wu,
T.-T. & Sun, R. (2003). Identification of proteins associated with
murine gammaherpesvirus 68 virions. J Virol 77, 13425–13432.
Bridgen, A. & Reid, H. W. (1991). Derivation of a DNA clone
corresponding to the viral agent of sheep-associated malignant
catarrhal fever. Res Vet Sci 50, 38–44.
Buxton, D., Reid, H. W., Finlayson, J. & Pow, I. (1984). Pathogenesis
of ‘sheep-associated’ malignant catarrhal fever in rabbits. Res Vet Sci
36, 205–211.
Buxton, D., Jacoby, R. O., Reid, H. W. & Goodall, P. A. (1988). The
pathology of ‘‘sheep-associated’’ malignant catarrhal fever in the
hamster. J Comp Pathol 98, 155–166.
Comeau, M. R., Johnson, R., DuBose, R. F., Petersen, M., Gearing,
P., VandenBos, T., Park, L., Farrah, T., Buller, R. M. & other authors
(1998). A poxvirus-encoded semaphorin induces cytokine produc-
tion from monocytes and binds to a novel cellular semaphorin
receptor, VESPR. Immunity 8, 473–482.
Coulter, L. J. & Reid, H. W. (2002). Isolation and expression of three
open reading frames from ovine herpesvirus-2. J Gen Virol 83, 533–543.
Cunningham, C. & Davison, A. J. (1993). A cosmid-based system for
constructing mutants of herpes simplex virus type 1. Virology 197,
116–124.
Deng, H., Chu, J. T., Park, N.-H. & Sun, R. (2004). Identification of cis
sequences required for lytic DNA replication and packaging of
murine gammaherpesvirus 68. J Virol 78, 9123–9131.
Devon, R. S., Porteous, D. J. & Brookes, A. J. (1995). Splinkerettes –
improved vectorettes for greater efficiency in PCR walking. Nucleic
Acids Res 23, 1644–1645.
Ensser, A., Pflanz, R. & Fleckenstein, B. (1997). Primary structure of
the alcelaphine herpesvirus 1 genome. J Virol 71, 6517–6525.
Ensser, A., Thurau, M., Wittmann, S. & Fickenscher, H. (2003). The
genome of herpesvirus saimiri C488 which is capable of transforming
human T cells. Virology 314, 471–487.
Fixman, E. D., Hayward, G. S. & Hayward, S. D. (1995). Replication
of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded
origin-binding protein and dependence on Zta in cotransfection
assays. J Virol 69, 2998–3006.
Gao, S.-J., Zhang, Y.-J., Deng, J.-H., Rabkin, C. S., Flore, O. &
Jenson, H. B. (1999). Molecular polymorphism of Kaposi’s sarcoma-
associated herpesvirus (human herpesvirus 8) latent nuclear antigen:
evidence for a large repertoire of viral genotypes and dual infection
with different viral genotypes. J Infect Dis 180, 1466–1476.
Gish, W. & States, D. J. (1993). Identification of protein coding
regions by database similarity search. Nat Genet 3, 266–272.
Goltz, M., Ericsson, T., Patience, C., Huang, C. A., Noack, S.,
Sachs, D. H. & Ehlers, B. (2002). Sequence analysis of the genome
of porcine lymphotropic herpesvirus 1 and gene expression during
posttransplant lymphoproliferative disease of pigs. Virology 294,
383–393.
Hamilton, A. F. (1990). Account of three outbreaks of malignant
catarrhal fever in cattle in the Republic of Ireland. Vet Rec 127,
231–232.
Holmes, S., Downs, A.-M., Fosberry, A., Hayes, P. D., Michalovich,
D., Murdoch, P., Moores, K., Fox, J., Deen, K. & other authors
(2002). Sema7A is a potent monocyte stimulator. Scand J Immunol
56, 270–275.
Hong, G. K., Delecluse, H.-J., Gruffat, H., Morrison, T. E., Feng, W.-H.,
Sergeant, A. & Kenney, S. C. (2004). The BRRF1 early gene of
Epstein-Barr virus encodes a transcription factor that enhances
induction of lytic infection by BRLF1. J Virol 78, 4983–4992.
Hu, J., Garber, A. C. & Renne, R. (2002). The latency-associated
nuclear antigen of Kaposi’s sarcoma-associated herpesvirus supports
latent DNA replication in dividing cells. J Virol 76, 11677–11687.
Hu¨ssy, D., Janett, F., Albini, S., Sta¨uber, N., Thun, R. & Ackermann,
M. (2002). Analysis of the pathogenetic basis for shedding and
transmission of ovine gamma herpesvirus 2. J Clin Microbiol 40,
4700–4704.
38 Journal of General Virology 88
J. Hart and others
Li, H., Snowder, G., O’Toole, D. & Crawford, T. B. (1998). Transmission
of ovine herpesvirus 2 in lambs. J Clin Microbiol 36, 223–226.
Li, H., Taus, N. S., Lewis, G. S., Kim, O., Traul, D. L. & Crawford, T. B.
(2004). Shedding of ovine herpesvirus 2 in sheep nasal secretions: the
predominant mode for transmission. J Clin Microbiol 42, 5558–5564.
Li, H., Taus, N. S., Jones, C., Murphy, B., Evermann, J. F. & Crawford,
T. B. (2006). A devastating outbreak of malignant catarrhal fever in a
bison feedlot. J Vet Diagn Invest 18, 119–123.
Lin, C. L., Li, H., Wang, Y., Zhu, F. X., Kudchodkar, S. & Yuan, Y.
(2003). Kaposi’s sarcoma-associated herpesvirus lytic origin (ori-
Lyt)-dependent DNA replication: identification of the ori-Lyt
and association of K8 bZip protein with the origin. J Virol 77,
5578–5588.
Loken, T., Aleksandersen, M., Reid, H. & Pow, I. (1998). Malignant
catarrhal fever caused by ovine herpesvirus-2 in pigs in Norway. Vet
Rec 143, 464–467.
Marshall, W. L., Yim, C., Gustafson, E., Graf, T., Sage, D. R., Hanify,
K., Williams, L., Fingeroth, J. & Finberg, R. W. (1999). Epstein-Barr
virus encodes a novel homolog of the bcl-2 oncogene that inhibits
apoptosis and associates with Bax and Bak. J Virol 73, 5181–5185.
May, J. S., Coleman, H. M., Boname, J. M. & Stevenson, P. G. (2005).
Murine gammaherpesvirus-68 ORF28 encodes a non-essential virion
glycoprotein. J Gen Virol 86, 919–928.
McGeoch, D. J., Rixon, F. J. & Davison, A. J. (2006). Topics in
herpesvirus genomics and evolution. Virus Res 117, 90–104.
Mu¨ller-Doblies, U. U., Li, H., Hauser, B., Adler, H. & Ackermann, M.
(1998). Field validation of laboratory tests for clinical diagnosis
of sheep-associated malignant catarrhal fever. J Clin Microbiol 36,
2970–2972.
Mu¨ller-Doblies, U. U., Egli, J., Hauser, B., Li, H., Strasser, M.,
Ehrensperger, F., Braun, U. & Ackermann, M. (2001). Malignant
catarrhal fever in Switzerland. 2. Evaluation of the diagnosis. Schweiz
Arch Tierheilkd 143, 581–591 (in German).
O’Toole, D., Li, H., Sourk, C., Montgomery, D. L. & Crawford, T. B.
(2002). Malignant catarrhal fever in a bison (Bison bison) feedlot,
1993-2000. J Vet Diagn Invest 14, 183–193.
Paulsen, S. J., Rosenkilde, M. M., Eugen-Olsen, J. & Kledal, T. N.
(2005). Epstein-Barr virus-encoded BILF1 is a constitutively active G
protein-coupled receptor. J Virol 79, 536–546.
Plowright, W., Ferris, R. D. & Scott, G. R. (1960). Blue wildebeest and
the aetiological agent of bovine malignant catarrhal fever. Nature
188, 1167–1169.
Reid, H. W., Buxton, D., Pow, I., Finlayson, J. & Berrie, E. L. (1983). A
cytotoxic T-lymphocyte line propagated from a rabbit infected with
sheep associated malignant catarrhal fever. Res Vet Sci 34, 109–113.
Reid, H. W., Buxton, D., Pow, I. & Finlayson, J. (1989). Isolation
and characterisation of lymphoblastoid cells from cattle and deer
affected with ‘sheep-associated’ malignant catarrhal fever. Res Vet Sci
47, 90–96.
Rice, P., Longden, I. & Bleasby, A. (2000). EMBOSS: the European
Molecular Biology Open Software Suite. Trends Genet 16, 276–277.
Rosbottom, J., Dalziel, R. G., Reid, H. W. & Stewart, J. P. (2002).
Ovine herpesvirus 2 lytic cycle replication and capsid production.
J Gen Virol 83, 2999–3002.
Rutherford, K., Parkhill, J., Crook, J., Horsnell, T., Rice, P.,
Rajandream, M.-A. & Barrell, B. (2000). Artemis: sequence
visualization and annotation. Bioinformatics 16, 944–945.
Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning:
a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold
Spring Harbor Laboratory.
Schock, A. & Reid, H. W. (1996). Characterisation of the
lymphoproliferation in rabbits experimentally affected with malig-
nant catarrhal fever. Vet Microbiol 53, 111–119.
Schock, A., Collins, R. A. & Reid, H. W. (1998). Phenotype,
growth regulation and cytokine transcription in Ovine herpesvirus-2
(OHV-2)-infected bovine T-cell lines. Vet Immunol Immunopathol
66, 67–81.
Schultheiss, P. C., Collins, J. K., Spraker, T. R. & DeMartini, J. C.
(2000). Epizootic malignant catarrhal fever in three bison herds:
differences from cattle and association with ovine herpesvirus-2. J Vet
Diagn Invest 12, 497–502.
Simon, S., Li, H., O’Toole, D., Crawford, T. B. & Oaks, J. L. (2003).
The vascular lesions of a cow and bison with sheep-associated
malignant catarrhal fever contain ovine herpesvirus 2-infected CD8+
T lymphocytes. J Gen Virol 84, 2009–2013.
Spriggs, M. K., Armitage, R. J., Comeau, M. R., Strockbine, L.,
Farrah, T., Macduff, B., Ulrich, D., Alderson, M. R., Mu¨llberg, J. &
Cohen, J. I. (1996). The extracellular domain of the Epstein-Barr
virus BZLF2 protein binds the HLA-DR b chain and inhibits antigen
presentation. J Virol 70, 5557–5563.
Stewart, J. P., Silvia, O. J., Atkin, I. M. D., Hughes, D. J., Ebrahimi, B.
& Adler, H. (2004). In vivo function of a gammaherpesvirus virion
glycoprotein: influence on B-cell infection and mononucleosis. J Virol
78, 10449–10459.
Swa, S., Wright, H., Thomson, J., Reid, H. & Haig, D. (2001).
Constitutive activation of Lck and Fyn tyrosine kinases in large
granular lymphocytes infected with the c-herpesvirus agents of
malignant catarrhal fever. Immunology 102, 44–52.
Tanner, J., Weis, J., Fearon, D., Whang, Y. & Kieff, E. (1987).
Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d
receptor mediates adsorption, capping, and endocytosis. Cell 50,
203–213.
Taus, N. S., Oaks, J. L., Gailbreath, K., Traul, D. L., O’Toole, D. & Li,
H. (2006). Experimental aerosol infection of cattle (Bos taurus) with
ovine herpesvirus 2 using nasal secretions from infected sheep. Vet
Microbiol 116, 29–36.
Taus, N. S., Herndon, D. R., Traul, D. L., Stewart, J. P., Ackermann,
M., Li, H., Knowles, D. P., Lewis, G. S. & Brayton, K. A. (2007).
Comparison of ovine herpesvirus 2 genomes isolated from domestic
sheep (Ovis aries) and a clinically affected cow (Bos bovis). J Gen
Virol 88, 40–45.
Thonur, L., Russell, G. C., Stewart, J. P. & Haig, D. M. (2006).
Differential transcription of ovine herpesvirus 2 genes in lympho-
cytes from reservoir and susceptible species. Virus Genes 32, 27–35.
Wiyono, A., Baxter, S. I. F., Saepulloh, M., Damayanti, R., Daniels, P.
& Reid, H. W. (1994). PCR detection of ovine herpesvirus-2 DNA in
Indonesian ruminants – normal sheep and clinical cases of malignant
catarrhal fever. Vet Microbiol 42, 45–52.
Wu, F. Y., Ahn, J.-H., Alcendor, D. J., Jang, W.-J., Xiao, J., Hayward,
S. D. & Hayward, G. S. (2001). Origin-independent assembly of
Kaposi’s sarcoma-associated herpesvirus DNA replication compart-
ments in transient cotransfection assays and association with the
ORF-K8 protein and cellular PML. J Virol 75, 1487–1506.
Zhang, Y.-J., Deng, J.-H., Rabkin, C. & Gao, S.-J. (2000). Hot-spot
variations of Kaposi’s sarcoma-associated herpesvirus latent nuclear
antigen and application in genotyping by PCR–RFLP. J Gen Virol 81,
2049–2058.
Zimmermann, W., Broll, H., Ehlers, B., Buhk, H. J., Rosenthal, A. &
Goltz, M. (2001). Genome sequence of bovine herpesvirus 4, a bovine
Rhadinovirus, and identification of an origin of DNA replication.
J Virol 75, 1186–1194.
http://vir.sgmjournals.org 39
Ovine herpesvirus 2 genome
